Method for detecting related substances in Tildipirosin raw material medicine and preparation of Tildipirosin raw material medicine
Through the HPLC-MS/MS method, combined with chromatography and mass spectrometry analysis, the detection conditions are optimized, and the problem of insufficient detection sensitivity and accuracy of new Tydiro raw materials in the existing technology is solved, and the detection effect of high sensitivity and high accuracy is achieved , suitable for batch inspection.
Patent Information
- Application Number
- CN202410905412.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-08
- Publication Date
- 2024-11-29
AI Technical Summary
The existing high performance liquid chromatography (HPLC) and gas chromatography (GC) have room for improvement in detecting the sensitivity, selectivity and accuracy of Tedirol's new raw materials and preparations, making it difficult to effectively detect and control impurities and The amount of degradation product.
The HPLC-MS/MS method is used to optimize the chromatographic and mass spectrometry conditions to improve detection accuracy and sensitivity through sample preparation, standard solution preparation, chromatographic analysis and mass spectrometry analysis steps, combined with external standard method quantitative calculation.
It realizes high sensitivity, selectivity and accuracy detection, can effectively detect extremely low content of impurities, simplify sample processing, and is suitable for batch testing.
Smart Images

Figure CN119044339A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of chemical drug detection, in particular to a method for detecting related substances in a tediluosin raw material drug and a preparation thereof. Background Art
[0002] As a new veterinary drug, Tildipirosin API and its injection have Tildipirosin and its isomers as the main active ingredients. Tildipirosin is a new type of macrolide semi-synthetic antibiotic with a 16-membered ring specifically for animals, and its structure is shown in the following structural formula I. Tildipirosin has high efficiency and broad-spectrum antibacterial activity, and has a good therapeutic effect on porcine respiratory diseases caused by Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus bronchiseptica and Haemophilus parasuis, and cattle respiratory diseases caused by Mannheimia hemolytica, Pasteurella multocida and Histophilus somnus. Tildipirosin injection is a sterile solution made of Tildipirosin API and suitable excipients. Since impurities may be introduced into the raw materials, intermediates, by-products and raw material synthesis in the synthesis process of the tadilaoxin API, and degradation products may be produced during the storage of the raw materials and injection solutions, it is necessary to establish appropriate chromatographic conditions and accurately detect the amounts of various related substances that may be present, so as to well control the quality of the samples. Currently available detection methods mainly include high performance liquid chromatography (HPLC), gas chromatography (GC), etc., but these methods still have room for improvement in terms of detection sensitivity, selectivity and accuracy. Summary of the invention
[0003] The object of the present invention is to provide a method for detecting related substances in tediluosin raw materials and preparations thereof, so as to solve the problems raised in the above-mentioned background technology.
[0004] To achieve the above object, the present invention provides the following technical solution: a method for detecting related substances in tediluosin raw materials and preparations thereof, comprising the following steps:
[0005] S1. Sample preparation: 10 mg of tediluosin API was dissolved in 10 mL of methanol. After ultrasonic treatment for 10 minutes, the supernatant was centrifuged and diluted to 100 mL, and filtered through a 0.22 μm filter membrane.
[0006] S2. Preparation of standard solution: Prepare standard solution of tediloxine and its related substances according to the above method, with a concentration range of 0.1-100 μg / mL;
[0007] S3, chromatographic analysis: Inject and test according to chromatographic conditions, and record the retention time and peak area of each component;
[0008] S4, mass spectrometry analysis: detect each component according to mass spectrometry conditions and record the response value of its characteristic ion pair;
[0009] S5. Data processing: The content of tedirox and its related substances in the sample is quantitatively calculated by the external standard method.
[0010] Preferably, the chromatographic conditions are: chromatographic column: C18 reverse phase column (250mm×4.6mm, 5μm), mobile phase A: 0.1% formic acid aqueous solution, mobile phase B: 0.1% formic acid acetonitrile solution, flow rate: 1.0mL / min, injection volume: 10μL, column temperature: 30°C, detection wavelength: 210nm.
[0011] Preferably, the mass spectrometry conditions are: ion source: electrospray ion source, mode: positive ion mode, collision gas: nitrogen, detection mode: multiple reaction monitoring.
[0012] Preferably, the chromatographic analysis step includes: starting the data processing software supporting the chromatograph, injecting the sample, running the chromatographic analysis program, after the chromatograph ends, the software automatically generates a chromatogram, through the peak calibration function in the software, select each peak, and record its retention time and peak area, export the recorded retention time and peak area for subsequent data processing and analysis, use the chromatogram of the standard solution, record the retention time and peak area of each concentration standard, draw a standard curve, use the chromatogram of the sample solution, record the retention time and peak area of each component in the sample, and calculate the concentration of each component in the sample through the standard curve.
[0013] Preferably, the mass spectrometry analysis step comprises dissolving a certain amount of tediloxine raw material or preparation in a methanol solvent to prepare a standard solution, selecting characteristic ion pairs according to the mass spectrometry fragmentation law of tediloxine and its impurities, optimizing the collision energy of each characteristic ion pair to make the signal strongest, optimizing the declustering voltage, and enhancing the generation of parent ions, respectively injecting the sample solution and the standard solution into the LC-MS / MS system, starting the LC-MS / MS analysis program, recording the chromatogram and mass spectrometry data, and after the operation is completed, obtaining a chromatogram and a mass spectrum, wherein each peak in the mass spectrum corresponds to the signal of a characteristic ion pair, recording the retention time of each component, and recording the response value of each characteristic ion pair, i.e., the peak area or peak height.
[0014] Preferably, the S5, data processing: quantitatively calculating the content of tediluosin and its related substances in the sample by external standard method, drawing a standard curve by standard solution, and then calculating the concentration of the target substance in the sample by the standard curve according to the response value of the sample.
[0015] Preferably, the method specifically comprises: preparing standard solutions of different concentrations of 0.1, 0.2, 0.5, 1.0, 2.0 and 5.0 μg / mL; injecting the standard solutions in sequence, recording the peak area or peak height, and then drawing a standard curve with the concentration of the standard solution as the abscissa and the peak area or peak height as the ordinate, and obtaining the standard curve equation by linear regression fitting: A=kC+b, wherein A is the peak area or peak height, C is the concentration, k is the slope of the standard curve, and b is the intercept.
[0016] Preferably, the sample solution is injected, the peak area or peak height is recorded, and the peak area or peak height A of the sample is calculated. sample , use the standard curve equation to calculate the concentration of tedirox and its related substances in the sample:
[0017]
[0018] Compared with the prior art, the present invention has the following beneficial effects:
[0019] 1. High sensitivity: The HPLC-MS / MS method has extremely high sensitivity and can detect extremely low levels of impurities.
[0020] 2. High selectivity: The multiple reaction monitoring mode can effectively separate tedirox and its related impurities to avoid interference.
[0021] 3. High accuracy: External standard method quantification can ensure the accuracy of the test results.
[0022] 4. Easy operation: Sample processing is simple, suitable for batch testing. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0024] Figure 1 The flowchart of the method for detecting related substances in the tediluosin raw material and its preparation according to Example 1 of the present invention;
[0025] Figure 2 The flowchart of the method for detecting related substances in the tediluosin raw material and its preparation according to Example 2 of the present invention;
[0026] Figure 3 It is a chromatographic analysis data diagram of the present invention;
[0027] Figure 4 It is a mass spectrometry data diagram of the present invention;
[0028] Figure 5 It is a record graph of the concentration peak area of the standard solution of the present invention. DETAILED DESCRIPTION
[0029] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0030] See also Figures 1 to 5 , the technical solution provided by the present invention:
[0031] Embodiment 1:
[0032] A method for detecting related substances in a tediluosin raw material drug and a preparation thereof comprises the following steps:
[0033] S1. Sample preparation: 10 mg of tediluosin API was dissolved in 10 mL of methanol. After ultrasonic treatment for 10 minutes, the supernatant was centrifuged and diluted to 100 mL, and filtered through a 0.22 μm filter membrane.
[0034] S2. Preparation of standard solution: Prepare standard solution of tediloxine and its related substances according to the above method, with a concentration range of 0.1-100 μg / mL;
[0035] S3, chromatographic analysis: Inject and test according to chromatographic conditions, and record the retention time and peak area of each component;
[0036] S4, mass spectrometry analysis: detect each component according to mass spectrometry conditions and record the response value of its characteristic ion pair;
[0037] S5. Data processing: The content of tedirox and its related substances in the sample is quantitatively calculated by the external standard method.
[0038] Embodiment 2:
[0039] A method for detecting related substances in a tediluosin raw material drug and a preparation thereof comprises the following steps:
[0040] S1. Sample preparation: Take an appropriate amount of tediloxine preparation, dilute it in methanol according to the proportion, and treat the sample according to the method of Example 1.
[0041] S2. Preparation of standard solution: Prepare the standard solution according to the method of Example 1.
[0042] S3. Chromatographic analysis: Inject and test according to chromatographic conditions, and record the retention time and peak area of each component.
[0043] S4. Mass spectrometry analysis: Detect each component according to mass spectrometry conditions and record the response value of its characteristic ion pair.
[0044] S5. Data processing: The content of tediluosin and its related substances in the sample was quantitatively calculated by the external standard method.
[0045] Ingredients and reagents: methanol: HPLC grade, acetonitrile: HPLC grade, formic acid: analytical grade, water: ultrapure water, standard substances: tediluosin and its related impurity standards.
[0046] Instruments and equipment: High performance liquid chromatography (HPLC), mass spectrometer (MS / MS), ultrasonic cleaner, micro-injector.
[0047] Specifically, the chromatographic conditions are as follows: chromatographic column: C18 reverse phase column (250 mm×4.6 mm, 5 μm), mobile phase A: 0.1% formic acid aqueous solution, mobile phase B: 0.1% formic acid acetonitrile solution, flow rate: 1.0 mL / min, injection volume: 10 μL, column temperature: 30°C, detection wavelength: 210 nm.
[0048] Specifically, the mass spectrometry conditions are: ion source: electrospray ion source, mode: positive ion mode, collision gas: nitrogen, detection mode: multiple reaction monitoring.
[0049] Specifically, the chromatographic analysis step includes: starting the data processing software supporting the chromatograph, injecting the sample, running the chromatographic analysis program, after the chromatograph is finished running, the software automatically generates a chromatogram, through the peak calibration function in the software, select each peak, and record its retention time and peak area, export the recorded retention time and peak area for subsequent data processing and analysis, use the chromatogram of the standard solution, record the retention time and peak area of each concentration standard, draw a standard curve, use the chromatogram of the sample solution, record the retention time and peak area of each component in the sample, and calculate the concentration of each component in the sample through the standard curve.
[0050] Specifically, the mass spectrometry analysis step includes dissolving a certain amount of tediloxine raw material or preparation in a methanol solvent to prepare a standard solution, selecting characteristic ion pairs according to the mass spectrometry fragmentation rules of tediloxine and its impurities, optimizing the collision energy of each characteristic ion pair to make the signal strongest, optimizing the declustering voltage, and enhancing the generation of parent ions, respectively injecting the sample solution and the standard solution into the LC-MS / MS system, starting the LC-MS / MS analysis program, recording the chromatogram and mass spectrometry data, and after the operation is completed, obtaining the chromatogram and mass spectrometry, each peak in the mass spectrometry corresponds to the signal of a characteristic ion pair, recording the retention time of each component, and recording the response value of each characteristic ion pair, that is, the peak area or peak height.
[0051] Specifically, the S5, data processing: quantitatively calculating the content of tediluosin and its related substances in the sample by the external standard method, drawing a standard curve by the standard solution, and then calculating the concentration of the target substance in the sample by the standard curve according to the response value of the sample.
[0052] Specifically, the method comprises: preparing standard solutions of different concentrations of 0.1, 0.2, 0.5, 1.0, 2.0 and 5.0 μg / mL; injecting the standard solutions in sequence, recording the peak areas or peak heights, and then drawing a standard curve with the concentration of the standard solution as the horizontal coordinate and the peak area or peak height as the vertical coordinate, and obtaining the standard curve equation by linear regression fitting: A=kC+b, wherein A is the peak area or peak height, C is the concentration, k is the slope of the standard curve, and b is the intercept.
[0053] Specifically, the sample solution is injected, the peak area or peak height is recorded, and the peak area or peak height A of the sample is calculated. sample , use the standard curve equation to calculate the concentration of tedirox and its related substances in the sample:
[0054]
[0055] The peak area of the sample is 1200, so the concentration of tediloxine in the sample is calculated as follows:
[0056]
[0057] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A method for detecting related substances in tediluosin raw materials and preparations thereof, characterized in that: The steps include: S1. Sample preparation: 10 mg of tediluosin API was dissolved in 10 mL of methanol. After ultrasonication for 10 minutes, the supernatant was centrifuged and diluted to 100 mL, and filtered through a 0.22 μm filter membrane. S2. Preparation of standard solution: Prepare standard solution of tediloxine and its related substances according to the above method, with a concentration range of 0.1-100 μg / mL; S3, chromatographic analysis: Inject and test according to chromatographic conditions, and record the retention time and peak area of each component; S4, mass spectrometry analysis: detect each component according to mass spectrometry conditions and record the response value of its characteristic ion pair; S5. Data processing: The content of tedirox and its related substances in the sample is quantitatively calculated by the external standard method.
2. The method for detecting related substances in a tediluosin raw material drug and its preparation according to claim 1, characterized in that: The chromatographic conditions are as follows: chromatographic column: C18 reverse phase column (250 mm×4.6 mm, 5 μm), mobile phase A: 0.1% formic acid aqueous solution, mobile phase B: 0.1% formic acid acetonitrile solution, flow rate: 1.0 mL / min, injection volume: 10 μL, column temperature: 30°C, detection wavelength: 210 nm.
3. The method for detecting related substances in a tediluosin raw material drug and its preparation according to claim 1, characterized in that: The mass spectrometry conditions are: ion source: electrospray ion source, mode: positive ion mode, collision gas: nitrogen, detection mode: multiple reaction monitoring.
4. The method for detecting related substances in a tediluosin raw material drug and its preparation according to claim 1, characterized in that: The chromatographic analysis step includes: starting the data processing software supporting the chromatograph, injecting the sample, running the chromatographic analysis program, after the chromatograph is finished running, the software automatically generates a chromatogram, through the peak calibration function in the software, selects each peak, and records its retention time and peak area, exports the recorded retention time and peak area for subsequent data processing and analysis, uses the chromatogram of the standard solution, records the retention time and peak area of each concentration standard, draws a standard curve, uses the chromatogram of the sample solution, records the retention time and peak area of each component in the sample, and calculates the concentration of each component in the sample through the standard curve.
5. The method for detecting related substances in a Tediroxine raw material drug and its preparation according to claim 1, characterized in that: The mass spectrometry analysis step comprises dissolving a certain amount of tediloxine raw material or preparation in a methanol solvent to prepare a standard solution, selecting characteristic ion pairs according to the mass spectrometry fragmentation rules of tediloxine and its impurities, optimizing the collision energy of each characteristic ion pair to make the signal strongest, optimizing the declustering voltage, enhancing the generation of parent ions, injecting the sample solution and the standard solution into the LC-MS / MS system respectively, starting the LC-MS / MS analysis program, recording the chromatogram and mass spectrometry data, and obtaining the chromatogram and mass spectrometry after the operation is completed, wherein each peak in the mass spectrometry corresponds to the signal of a characteristic ion pair, recording the retention time of each component, and recording the response value of each characteristic ion pair, that is, the peak area or peak height.
6. The method for detecting related substances in a Tediroxine raw material drug and its preparation according to claim 1, characterized in that: S5, data processing: quantitatively calculating the content of tediluosin and its related substances in the sample by external standard method, drawing a standard curve by standard solution, and then calculating the concentration of the target substance in the sample by the standard curve according to the response value of the sample.
7. The method for detecting related substances in a Tediroxine raw material drug and its preparation according to claim 6, characterized in that: Specifically include: Prepare standard solutions of different concentrations: 0.1, 0.2, 0.5, 1.0, 2.0, 5.0 μg / mL; The standard solution was injected in sequence, and the peak area or peak height was recorded. Then, the standard curve was drawn with the concentration of the standard solution as the horizontal axis and the peak area or peak height as the vertical axis. The standard curve equation was obtained by linear regression fitting: A = kC + b. In the figure, A is the peak area or height, C is the concentration, k is the slope of the standard curve, and b is the intercept.
8. The method for detecting related substances in a Tediroxine raw material drug and its preparation according to claim 7, characterized in that: Inject the sample solution, record the peak area or peak height, and calculate the peak area or peak height A according to the peak area or peak height A of the sample. sample , use the standard curve equation to calculate the concentration of tedirox and its related substances in the sample:
